KalGene Pharmaceuticals Inc. an Alzheimer’s focused company using a next generation engineered drug candidate, has appointed new leadership
Mr. Anthony J. Giovinazzo joins as Executive Chairman; and Dr. Nickolay V. Kukekov, Ph.D. as President and CEO KalGene also announced that concurrent with the appointment of new leadership, the Company has closed on a substantial amount of capital from US institutions and family offices to progress KG207 to clinical testing MONTREAL and TORONTO, Aug. 5, 2021 […]